ClinicalTrials.gg
RecruitingNCT07387783Updated Apr 29, 2026

Sleep Quality and Cognitive Functions in Adults: A Cross-Sectional Study

An observational study in Sleep Quality and Cognitive Functions, sponsored by Uskudar University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-29.

Sponsored by Uskudar University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Jan 2026; still recruiting 9 months later.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
75
Ages
18 Years to 35 Years
Sex
All
01

Study summary

This observational cross-sectional study aims to examine the association between sleep quality and cognitive functions in healthy young adults. Subjective sleep quality will be assessed using the Pittsburgh Sleep Quality Index, and objective sleep parameters will be collected using a wearable device over five consecutive days. Cognitive functions will be evaluated at a single assessment session using standardized neuropsychological tests, including measures of attention, executive functions, and verbal memory. The study seeks to explore relationships between subjective and objective sleep measures and cognitive performance. Findings from this study may contribute to a better understanding of how sleep quality is associated with cognitive functioning in healthy young adults.

Read the detailed description

This study is designed as an observational, cross-sectional investigation conducted in healthy young adults to examine the association between sleep quality and cognitive functions. Participants will be recruited from a non-clinical population and will undergo a single assessment period. Subjective sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI), a self-report questionnaire evaluating sleep quality and sleep-related disturbances over the previous month. In addition to subjective measures, objective sleep parameters will be collected using a wearable device worn continuously for five consecutive days. Wearable-derived sleep metrics will include total sleep time, sleep efficiency, sleep onset latency, and wake after sleep onset, as provided by the device's standard algorithms. Cognitive functions will be evaluated during a single in-person assessment session following completion of the sleep data collection period. Cognitive assessment will include standardized neuropsychological tests measuring attention, executive functions, and verbal memory. Attention and executive functions will be assessed using the Victoria Stroop Test, and verbal memory processes will be evaluated using the Öktem Verbal Memory Processes Test, administered according to standardized procedures. Demographic information and relevant background variables will be collected to characterize the study sample. Statistical analyses will primarily focus on examining associations between subjective and objective sleep parameters and cognitive test outcomes. Correlation analyses and multivariable statistical models may be used to explore relationships between sleep quality and cognitive performance while accounting for potential confounding variables. This study aims to contribute to the understanding of how variations in sleep quality are associated with cognitive functioning in healthy young adults, using both subjective and objective sleep measures.

02

Conditions studied

  • Sleep Quality
  • Cognitive Functions

Keywords

  • sleep quality
  • Cognitive Function
  • Young Adults
  • verbal memory
  • wearable device
03

In context

Sleep Initiation and Maintenance Disorders

2,722 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 726 are open to participants now.

This study's planned enrollment of 75 is below the median of 138 across 318 observational studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Uskudar University is the lead sponsor of 170 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of healthy young adults aged between 18 and 35 years. Participants are recruited from a non-clinical population and are required to be fluent in Turkish to ensure valid administration of cognitive assessments. Individuals with self-reported good general health and without active medical, neurological, or psychiatric conditions that may affect sleep or cognitive functioning are eligible. All participants are able and willing to comply with the study procedures, including wearing a wearable sleep monitoring device for five consecutive days and completing a single-session cognitive assessment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between 18 and 35 years.
  • Ability and willingness to provide written .
  • Sufficient ability to read, understand, and communicate in Turkish, the language in which the assessments are administered.
  • Self-reported good general health, with no active medical or psychiatric conditions that significantly affect daily functioning.
  • Willingness and ability to wear a wearable sleep monitoring device continuously for five consecutive days and to comply with device usage instructions.
  • Ability to attend and complete a single-session cognitive assessment

Exclusion criteria

Exclusion Criteria:

  • Regular or frequent use of medications known to affect sleep or cognitive function, including sedative-hypnotics, benzodiazepines, antipsychotics, stimulants, opioids, or similar agents.
  • Initiation of, or dose changes in, psychotropic medications within the past four weeks.
  • Being under the influence of alcohol or illicit substances on the day of cognitive testing.
  • Engagement in night shift work or rotating shift schedules within the past one month.
  • Travel across time zones resulting in a time difference of two hours or more within the past two weeks.
  • Uncontrolled high daily intake of caffeine (e.g., >400 mg/day) and unwillingness to reduce consumption during the study period.
  • Color blindness or other color vision deficiencies, due to their potential impact on Stroop Test performance.
  • Dermatological conditions, allergies, or skin lesions at the wrist that prevent wearing the device, or refusal to wear the device as required.
  • Acute illness within the past two weeks, including febrile infections, severe pain, or other acute medical conditions that may temporarily affect sleep or cognitive performance.
  • Pregnancy or early postpartum period.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
75 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthy Young Adults

    Healthy young adult participants without diagnosed neurological, psychiatric, or sleep disorders who undergo assessment of sleep quality and cognitive functions during a single observational assessment period.

06

What researchers measure

Primary outcomes

  1. Composite Objective Sleep Quality Index Derived From Wearable Device

    A composite objective sleep quality index will be derived from wearable device data collected continuously over five consecutive days. The composite score will be calculated by combining standardized values of total sleep time, sleep efficiency, sleep onset latency, and wake after sleep onset into a single summary measure representing overall objective sleep quality.

    Time frame: During 5 consecutive days around baseline assessment

Secondary outcomes

  1. Sleep Quality (Pittsburgh Sleep Quality Index Scores)

    Subjective sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The total PSQI score ranges from 0 to 21, with higher scores indicating poorer sleep quality.

    Time frame: Baseline (single assessment)

  2. Cognitive Performance (Victoria Stroop Test Scores)

    Attention and executive functions will be assessed using the Victoria Stroop Test. Outcome measures include completion time and error scores obtained during the test.

    Time frame: Baseline (single assessment)

  3. Verbal Memory Performance (Öktem Verbal Memory Processes Test Scores)

    Verbal memory will be evaluated using the Öktem Verbal Memory Processes Test. Outcome measures include standardized scores reflecting learning and recall performance.

    Time frame: Baseline (single assessment)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study involves sensitive personal data related to sleep patterns and cognitive performance, and participant consent for data sharing was not obtained. Data will be used solely for the purposes defined in the approved study protocol.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07387783
Lead sponsor
Uskudar University
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Fatma Demir (Principal Investigator, Uskudar University) — Principal investigator
First posted
Feb 4, 2026
Start date
Jan 26, 2026
Primary completion
Jun 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Apr 29, 2026

Study contacts

Fatma Demir
Contact
fatma.demir@uskudar.edu.tr
(0216) 400 22 22
Fatma Demir, MSc
principal investigator · Üsküdar University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion